Jacobs Levy Equity Management Portfolio holdings
AUM
$25.5B
1-Year Return
20.81%
This Quarter Return
+12.88%
1 Year Return
+20.81%
3 Year Return
+97.14%
5 Year Return
+210.43%
10 Year Return
+444.59%
AUM
$25.5B
AUM Growth
+$295M
(+1.2%)
Cap. Flow
-$1.98B
Cap. Flow
% of AUM
-7.77%
Top 10 Holdings %
Top 10 Hldgs %
26.12%
Holding
1,192
New
132
Increased
326
Reduced
512
Closed
172
Top Buys
| 1 |
Qualcomm
QCOM
|
$311M |
| 2 |
GE Vernova
GEV
|
$242M |
| 3 |
Fortinet
FTNT
|
$185M |
| 4 |
Monster Beverage
MNST
|
$182M |
| 5 |
General Motors
GM
|
$171M |
Top Sells
| 1 |
Palo Alto Networks
PANW
|
$339M |
| 2 |
Lam Research
LRCX
|
$243M |
| 3 |
Microsoft
MSFT
|
$239M |
| 4 |
Spotify
SPOT
|
$198M |
| 5 |
Apple
AAPL
|
$197M |
Sector Composition
| 1 | Technology | 31.6% |
| 2 | Industrials | 13.07% |
| 3 | Financials | 13.04% |
| 4 | Consumer Discretionary | 12.88% |
| 5 | Healthcare | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
LINE
951
Lineage, Inc. Common Stock
LINE
$9.29B
| $267K | ﹤0.01% |
+6,140
| New | +$267K |
|
952
BioLife Solutions
BLFS
$1.27B
| $267K | ﹤0.01% |
12,394
| – | – |
|
953
Levi Strauss
LEVI
$8.79B
| $266K | ﹤0.01% |
14,391
| – | – |
|
|
IMA
954
ImageneBio, Inc. Common Stock
IMA
$89M
| $265K | ﹤0.01% |
16,509
-3,948
| -19% | -$63.5K |
|
955
MRC Global
MRC
$1.28B
| $261K | ﹤0.01% |
19,029
| – | – |
|
956
Personalis
PSNL
$465M
| $260K | ﹤0.01% |
39,629
-327,333
| -89% | -$2.15M |
|
957
Sinclair Inc
SBGI
$964M
| $260K | ﹤0.01% |
+18,806
| New | +$260K |
|
958
CSP Inc
CSPI
$112M
| $259K | ﹤0.01% |
+20,006
| New | +$259K |
|
959
Forrester Research
FORR
$187M
| $256K | ﹤0.01% |
25,872
+9,742
| +60% | +$96.4K |
|
960
American Woodmark
AMWD
$997M
| $254K | ﹤0.01% |
+4,766
| New | +$254K |
|
961
Cable One
CABO
$922M
| $253K | ﹤0.01% |
+1,866
| New | +$253K |
|
962
Guaranty Bancshares
GNTY
$562M
| $251K | ﹤0.01% |
5,905
-19,268
| -77% | -$818K |
|
963
Mativ Holdings
MATV
$680M
| $243K | ﹤0.01% |
+35,600
| New | +$243K |
|
964
OP Bancorp
OPBK
$212M
| $241K | ﹤0.01% |
+18,527
| New | +$241K |
|
965
USCB Financial Holdings
USCB
$350M
| $239K | ﹤0.01% |
14,479
-14,600
| -50% | -$241K |
|
966
Cardlytics
CDLX
$49.6M
| $239K | ﹤0.01% |
145,478
-562
| -0.4% | -$924 |
|
967
Limoneira
LMNR
$285M
| $226K | ﹤0.01% |
14,436
| – | – |
|
968
Cato Corp
CATO
$87.2M
| $225K | ﹤0.01% |
79,979
+27,714
| +53% | +$77.9K |
|
969
Howmet Aerospace
HWM
$71.8B
| $224K | ﹤0.01% |
+1,206
| New | +$224K |
|
970
Bankwell Financial Group
BWFG
$339M
| $224K | ﹤0.01% |
+6,207
| New | +$224K |
|
971
Theravance Biopharma
TBPH
$703M
| $223K | ﹤0.01% |
20,174
-141,623
| -88% | -$1.56M |
|
972
PTC Therapeutics
PTCT
$4.55B
| $222K | ﹤0.01% |
4,542
-31,527
| -87% | -$1.54M |
|
|
MITT
973
AG Mortgage Investment Trust
MITT
$247M
| $221K | ﹤0.01% |
+29,279
| New | +$221K |
|
974
Syndax Pharmaceuticals
SNDX
$1.47B
| $220K | ﹤0.01% |
+23,530
| New | +$220K |
|
975
Altria Group
MO
$112B
| $220K | ﹤0.01% |
3,747
-74,299
| -95% | -$4.36M |
|